MARK DEMETRIOS: Open Payments
NPI 1285067801 · BOARDMAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,164 in 105 payments from 17 companies in 2025. Trend: 2023 $1,466 · 2024 $1,290 · 2025 $2,164
Food & beverage: $2,164
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 29 | $480 |
| E.R. Squibb & Sons, L.L.C. | 11 | $295 |
| Tris Pharma Inc | 4 | $253 |
| Axsome Therapeutics, Inc. | 8 | $243 |
| ABBVIE INC. | 14 | $219 |
| Corium, LLC | 12 | $180 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $115 |
| Collegium Pharmaceutical, Inc. | 6 | $103 |
| Supernus Pharmaceuticals, Inc. | 5 | $83 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
Products named: FANAPT, COBENFY, Dyanavel XR, Auvelity, VRAYLAR, Azstarys, CAPLYTA, Jornay PM.
Industry payments across OH — which companies pay providers there.
